PSNL Personalis, Inc.
$15.98▲ +0.63%
Healthcare
Other
After hours
$15.98▲ +0.00%
Oct 27, 4:01 PM ET
Volume 1.83M
Avg Volume (10D) 2.58M
Key Metrics & Fundamentals
Market Cap
$1.71B
P/E Ratio
–
Div Yield
0.00%
52W Range
4.96 - 18.89
% vs 50 MA
-2.05%
% vs 200 MA
42.92%
RSI-14
50.1
MACD Histogram
-0.0100
Beta (1Y vs SPY)
2.77
Free Cash Flow
-$29.55M
Gross Rev
$22.36M
Gross Profit
$4.74M
EBITDA
-$29.23M
COGS
$17.61M
Operating Exp
$38.33M
Operating Income
-$33.59M
EBIT
-$33.59M
Pretax Income
-$31.68M
Net Income
-$31.68M
EPS (Diluted)
-0.30
Price & Volume History
Loading chart…
Recent News
The $1.5 Billion Question Facing Tempus AI Ahead of Nov. 2 Earnings
24/7 Wall St. · Oct 27, 2026 9:28 AM ET
What Happens To Tempus AI Stock If Its Cash Burn Continues?
Trefis · Oct 26, 2026 8:47 AM ET
Personalis NeXT Personal® Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026
Business Wire · Oct 21, 2026 6:00 AM ET
Personalis Brings Resistance Mutation Tracking to NeXT Personal® MRD Test
Business Wire · Oct 20, 2026 6:00 AM ET
Personalis (PSNL) Stock Looks Richly Valued As Shares Surge 14x In 3 Years
Simply Wall St. · Oct 20, 2026 2:11 AM ET
BTIG Downgrades Personalis to Neutral From Buy
MT Newswires · Oct 6, 2026 6:34 AM ET
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion
MarketBeat · Sep 21, 2026 8:02 PM ET
Tempus AI Stock Surges as Revenue Optimism Boosts Winning Streak
Barrons.com · Sep 17, 2026 2:34 PM ET
The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels.
The Wall Street Journal · Sep 4, 2026 5:30 AM ET
Piper Sandler Lifts Tempus AI to Overweight at $76
GuruFocus.com · Sep 1, 2026 9:45 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PSNL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.